Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VizX Labs was a Seattle-based bioinformatics company that specialized in software solutions for genomic data analysis and visualization. The company's flagship product, GeneSifter, was a web-based platform designed to help researchers manage and interpret high-dimensional data from microarrays and next-generation sequencing (NGS). By providing automated analysis pipelines and intuitive visualization tools, VizX Labs enabled scientists to identify significant genetic patterns and biological pathways without requiring extensive programming knowledge. The company's technology was widely adopted by academic institutions and pharmaceutical companies to streamline the transition from raw genetic data to biological insights. In 2011, VizX Labs was acquired by Geospiza, which was subsequently acquired by PerkinElmer to bolster its genomic analysis portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VizX Labs.